Brian Varnum
Net worth: 162 849 $ as of 2024-03-30
Career history of Brian Varnum
Former positions of Brian Varnum
Companies | Position | Start | End |
---|---|---|---|
ARMATA PHARMACEUTICALS, INC. | Director/Board Member | 2021-08-01 | 2023-07-10 |
Chief Executive Officer | 2021-08-01 | 2023-07-10 | |
President | 2019-05-08 | 2021-08-01 | |
C3 Jian LLC
C3 Jian LLC BiotechnologyHealth Technology C3 Jian, Inc. operates as a biotechnological research and development company. It provides development and commercialization of pathogen-specific and antimicrobials that treat and prevent diseases caused by microbial dysbiosis. The company is headquartered in Marina del Rey, CA. | Corporate Officer/Principal | 2012-02-29 | 2019-04-30 |
C3J Therapeutics, Inc.
C3J Therapeutics, Inc. BiotechnologyHealth Technology C3J Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of novel targeted antimicrobials-synthetic bacteriophage and antimicrobial peptides. The company was founded by Randal Eckert, Maxwell H. Anderson and Wenyuan Shi in 2005 and is headquartered in Marina del Rey, CA. | Corporate Officer/Principal | 2011-12-31 | - |
Training of Brian Varnum
University of California, Los Angeles | Doctorate Degree |
University of California | Undergraduate Degree |
Statistics
International
United States | 6 |
Operational
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ARMATA PHARMACEUTICALS, INC. | Health Technology |
Private companies | 2 |
---|---|
C3 Jian LLC
C3 Jian LLC BiotechnologyHealth Technology C3 Jian, Inc. operates as a biotechnological research and development company. It provides development and commercialization of pathogen-specific and antimicrobials that treat and prevent diseases caused by microbial dysbiosis. The company is headquartered in Marina del Rey, CA. | Health Technology |
C3J Therapeutics, Inc.
C3J Therapeutics, Inc. BiotechnologyHealth Technology C3J Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of novel targeted antimicrobials-synthetic bacteriophage and antimicrobial peptides. The company was founded by Randal Eckert, Maxwell H. Anderson and Wenyuan Shi in 2005 and is headquartered in Marina del Rey, CA. | Health Technology |
- Stock Market
- Insiders
- Brian Varnum
- Experience